CKD 385
Alternative Names: CKD-385Latest Information Update: 28 Feb 2024
At a glance
- Originator Chong Kun Dang
- Class Antihyperlipidaemics; Antihypertensives; Cardiovascular therapies; Heart failure therapies; Ischaemic heart disorder therapies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Angina pectoris; Cardiovascular disorders; Heart failure; Hypertension
Most Recent Events
- 28 Feb 2024 No recent reports of development identified for phase-I development in Angina-pectoris in South Korea (PO, Tablet)
- 28 Feb 2024 No recent reports of development identified for phase-I development in Cardiovascular-disorders(In volunteers) in South Korea (PO, Tablet)
- 28 Feb 2024 No recent reports of development identified for phase-I development in Heart-failure in South Korea (PO)